Total Payments
$5,329
2024 Payments
$218.02
Companies
23
Transactions
72
Medicare Patients
3,393
Medicare Billing
$268,963
Payment Breakdown by Category
Food & Beverage$2,556 (48.0%)
Travel$2,373 (44.5%)
Other$400.00 (7.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,556 | 61 | 48.0% |
| Travel and Lodging | $2,373 | 10 | 44.5% |
| Grant | $400.00 | 1 | 7.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $2,103 | 12 | $0 (2019) |
| Cook Medical LLC | $909.09 | 4 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $252.30 | 6 | $0 (2023) |
| Medtronic, Inc. | $252.03 | 2 | $0 (2023) |
| Inari Medical, Inc. | $165.93 | 3 | $0 (2024) |
| HeartFlow, Inc. | $159.75 | 2 | $0 (2022) |
| CVRx, Inc. | $153.13 | 3 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $150.06 | 5 | $0 (2022) |
| ACIST MEDICAL SYSTEMS, INC. | $147.07 | 1 | $0 (2019) |
| Biosense Webster, Inc. | $145.37 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $218.02 | 5 | Biosense Webster, Inc. ($145.37) |
| 2023 | $771.45 | 9 | Medtronic, Inc. ($252.03) |
| 2022 | $207.41 | 7 | HeartFlow, Inc. ($102.81) |
| 2021 | $342.79 | 17 | Janssen Pharmaceuticals, Inc ($105.48) |
| 2020 | $150.72 | 3 | PFIZER INC. ($125.00) |
| 2019 | $1,349 | 12 | Medtronic Vascular, Inc. ($1,053) |
| 2018 | $2,227 | 15 | Medtronic Vascular, Inc. ($1,051) |
| 2017 | $61.98 | 4 | Astellas Pharma US Inc ($29.09) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Biosense Webster, Inc. | NUVISION ICE CATHETER (Device) | Food and Beverage | In-kind items and services | $145.37 | General |
| Category: Cardiology | ||||||
| 08/22/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/21/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 01/08/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: VTE | ||||||
| 10/17/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $16.63 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/09/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $135.47 | General |
| Category: VTE | ||||||
| 08/09/2023 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $108.55 | General |
| Category: Stents | ||||||
| 08/03/2023 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $143.48 | General |
| Category: Pacemakers | ||||||
| 07/21/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: VTE | ||||||
| 07/19/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/12/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $91.11 | General |
| Category: Cardiovascular | ||||||
| 07/12/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $13.90 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/11/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $122.60 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/14/2022 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $102.81 | General |
| Category: Coronary | ||||||
| 03/23/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/16/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/09/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Cardiology | ||||||
| 02/16/2022 | Coala Life Inc | Coala Heart Monitor (Device) | Food and Beverage | Cash or cash equivalent | $13.84 | General |
| Category: Cardiology | ||||||
| 02/09/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/12/2022 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/15/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/01/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/27/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 708 | 938 | $293,267 | $70,332 |
| 2022 | 14 | 848 | 925 | $326,680 | $66,118 |
| 2021 | 14 | 1,159 | 1,291 | $407,843 | $113,191 |
| 2020 | 9 | 678 | 940 | $63,153 | $19,322 |
Total Patients
3,393
Total Services
4,094
Medicare Billing
$268,963
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 52 | 52 | $58,102 | $13,878 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 135 | $40,230 | $12,709 | 31.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 45 | 174 | $26,970 | $7,986 | 29.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 32 | 68 | $19,652 | $6,342 | 32.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 92 | 93 | $19,065 | $4,754 | 24.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 42 | 42 | $15,960 | $4,277 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $13,680 | $3,525 | 25.8% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 45 | 45 | $36,295 | $3,204 | 8.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 19 | 19 | $13,965 | $2,906 | 20.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 11 | 14 | $8,624 | $2,337 | 27.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 37 | $7,474 | $2,231 | 29.9% |
| 93355 | Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | Facility | 2023 | 12 | 12 | $7,632 | $2,053 | 26.9% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 47 | 47 | $7,614 | $956.10 | 12.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 79 | 85 | $4,930 | $920.86 | 18.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 49 | 49 | $3,332 | $803.98 | 24.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $3,102 | $661.18 | 21.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 11 | 11 | $5,520 | $535.47 | 9.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 13 | 14 | $1,120 | $253.11 | 22.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 248 | 248 | $216,196 | $40,385 | 18.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 63 | $19,194 | $5,097 | 26.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 229 | 236 | $16,048 | $4,079 | 25.4% |
| 93356 | Heart muscle strain imaging | Office | 2022 | 89 | 89 | $12,015 | $3,176 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 29 | $9,447 | $2,634 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $10,304 | $2,562 | 24.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 41 | 41 | $13,071 | $2,146 | 16.4% |
About Dr. Ahmed Ibrahim, MD
Dr. Ahmed Ibrahim, MD is a Cardiovascular Disease healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2010. The National Provider Identifier (NPI) number assigned to this provider is 1639481989.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ahmed Ibrahim, MD has received a total of $5,329 in payments from pharmaceutical and medical device companies, with $218.02 received in 2024. These payments were reported across 72 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,556).
As a Medicare-enrolled provider, Ibrahim has provided services to 3,393 Medicare beneficiaries, totaling 4,094 services with total Medicare billing of $268,963. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Internal Medicine
- Location El Paso, TX
- Active Since 07/01/2010
- Last Updated 04/19/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639481989
Products in Payments
- Resolute (Device) $2,103
- ELIQUIS (Drug) $297.17
- FLOWTRIEVER CATHETER, S (Device) $165.93
- Barostim Neo System (Device) $153.13
- HD-IVUS (Device) $147.07
- NUVISION ICE CATHETER (Device) $145.37
- MICRA (Device) $143.48
- XARELTO (Drug) $138.95
- FARXIGA (Drug) $124.99
- RESOLUTE ONYX (Device) $108.55
- FFRct (Device) $102.81
- PRALUENT ALIROCUMAB INJECTION (Biological) $96.23
- CAMZYOS (Drug) $91.11
- ENTRESTO (Drug) $60.52
- Vascepa (Drug) $59.55
- PRALUENT (Drug) $54.53
- VERQUVO (Drug) $53.60
- JARDIANCE (Drug) $50.09
- WATCHMAN FLX (Device) $37.42
- MULTAQ (Drug) $37.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in El Paso
Dr. Mohammad Raja, Md, MD
Cardiovascular Disease — Payments: $419,675
Cardiovascular Disease $419,675
Tu Cao, Do, DO
Cardiovascular Disease — Payments: $103,141
Cardiovascular Disease $103,141
Mr. Edward Assi, D.o, D.O
Cardiovascular Disease — Payments: $100,993
Cardiovascular Disease $100,993
Oscar Munoz, Md, MD
Cardiovascular Disease — Payments: $64,052
Cardiovascular Disease $64,052
Ediberto Soto-Cora, M.d, M.D
Cardiovascular Disease — Payments: $47,917
Cardiovascular Disease $47,917
Dr. Arshad Ali, Md, MD
Cardiovascular Disease — Payments: $26,863
Cardiovascular Disease $26,863